Scarica l'app Stockscreener
0.50
3.82%
0.0184
Pre-mercato:
.55
0.05
+10.00%
Precedente Chiudi:
$0.4816
Aprire:
$0.4818
Volume 24 ore:
128.25K
Relative Volume:
0.78
Capitalizzazione di mercato:
$70.03M
Reddito:
$133.93M
Utile/perdita netta:
$4.97M
Rapporto P/E:
14.97
EPS:
0.0334
Flusso di cassa netto:
$10.12M
1 W Prestazione:
+4.89%
1M Prestazione:
-18.67%
6M Prestazione:
-34.22%
1 anno Prestazione:
+11.36%
Intervallo 1D:
$0.4816
$0.52
Intervallo di 1 settimana:
$0.4766
$0.5288
Portata 52W:
$0.3901
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Nome
Xtant Medical Holdings Inc
Settore
Industria
Telefono
406-388-0480
Indirizzo
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.50 | 67.46M | 133.93M | 4.97M | 10.12M | 0.0334 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-05 | Iniziato | BTIG Research | Buy |
| 2018-11-15 | Reiterato | Maxim Group | Buy |
| 2018-02-14 | Reiterato | Maxim Group | Buy |
Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie
Xtant Medical (XTNT): Buy Rating and Growth Prospects Highlighted - GuruFocus
Xtant Medical Holdings, Inc. (XTNT) - Minichart
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Growth in Short Interest - MarketBeat
Xtant Medical acquires exclusive U.S. rights to HEMOBLAST Bellows By Investing.com - Investing.com Australia
Xtant Medical Holdings, Inc. and Dilon Technologies, Inc Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product - marketscreener.com
Xtant Medical Secures Exclusive U.S. Distribution Rights for Dilon’s HEMOBLAST Bellows Hemostatic Product and Expands Sales Team - Minichart
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal - TipRanks
Xtant Medical acquires exclusive U.S. rights to HEMOBLAST Bellows - Investing.com
Xtant Medical (XTNT) pays $5M for exclusive U.S. HEMOBLAST rights, adds 20 sales staff - Stock Titan
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product - PR Newswire
Breakout Move: Can Xtant Medical Holdings Inc outperform under higher oil pricesTrade Analysis Report & High Win Rate Trade Alerts - baoquankhu1.vn
Sentiment Watch: Is Xtant Medical Holdings Inc stock overvalued or fairly priced2026 EndofYear Setup & Smart Swing Trading Techniques - baoquankhu1.vn
Meme Stocks: Can Xtant Medical Holdings Inc deliver consistent dividends2026 Stock Rankings & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial - Barchart.com
Craig-Hallum Maintains Buy on Xtant Medical Holdings, Inc. (XTNT) March 2026 - Meyka
Montana plans donor memorial as 86% of residents register - Stock Titan
XTNT PE Ratio & Valuation, Is XTNT Overvalued - Intellectia AI
XTNT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Craig-Hallum Maintains Buy on Xtant Medical (XTNT) March 18, 2026 - Meyka
Xtant Medical Earnings Call Highlights Profitability Turnaround - The Globe and Mail
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results - Orthopedics This Week
Xtant Medical (NYSEAMERICAN:XTNT) Issues Quarterly Earnings Results - MarketBeat
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2025 Earnings Call Transcript - Insider Monkey
Xtant Medical Achieves Profitability and 14% Revenue Growth in 2025, Provides 2026 Outlook After Strategic Divestiture - Minichart
Xtant Medical (NYSEAMERICAN:XTNT) Price Target Cut to $1.00 by Analysts at BTIG Research - Defense World
Xtant outlines $95M-$99M 2026 revenue outlook as Companion Spine divestiture and Q-code license revenue roll off - msn.com
Latest XTNT NewsXtant Medical Announces Debt Restructuring - Stock Titan
Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
XTNT Stock Update: Analyst Lowers Price Target Amid Buy Rating | - GuruFocus
Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat - MSN
Xtant Medical Q4 2025 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings, Inc. 2025 Annual Report: Orthobiologics, Spinal Implants, and Company Overview - Minichart
Xtant Medical Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
XTNT: 2025 saw double-digit revenue growth and profitability, with 2026 focused on core biologics acceleration - TradingView — Track All Markets
American Shared Hospital Services (AMS) Reports Q4 Earnings - news.alphastreet.com
Xtant Medical Holdings, Inc. (XTNT) Reports In-Line Q4 Earnings - AlphaStreet
Xtant Medical Holdings 2025 10-K: $133.9M Revenue, $0.03 Diluted EPS - TradingView
XTNT: 2025 net income of $5.0M driven by one-time gains; 2026 outlook pressured by lost license revenue - TradingView — Track All Markets
Xtant Medical (NYSE: XTNT) sheds one-time 2025 gains, sells Coflex/CoFix assets - Stock Titan
Xtant Medical Holdings reports FY2025 revenue $133.9M, net income $5.0M and adjusted EBITDA $16.3M - TradingView
XTNT: 2025 saw 14% revenue growth, profitability, and a strategic shift to core biologics - TradingView — Track All Markets
Form 8-KCurrent report - ADVFN
Xtant Medical Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Breakout Watch: Is Xtant Medical Holdings Inc stock a value trapMarket Growth Report & Consistent Growth Stock Picks - baoquankhu1.vn
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Increase in Short Interest - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
Craig-Hallum Maintains Buy on Xtant Medical (XTNT) March 2026 - Meyka
Market Pulse: What hedge funds are buying Xtant Medical Holdings IncCPI Data & Pattern Based Trade Signal System - baoquankhu1.vn
Xtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026 - Finviz
If You Invested $1,000 in Xtant Medical (XTNT) - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market SessionAzitra (AMEX:AZTR), Bullfrog AI Hldgs (NASDAQ:BFRG) - Benzinga
Xtant Medical Holdings Inc Azioni (XTNT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):